gvtcx

Framework for the Ongoing Supply of Nucleotides

CENTRE FOR PROCESS INNOVATION LIMITED Published 8 Jun 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,000,000
Statuscomplete
Category (CPV) 24000000 +1 more
RegionNorth East
Deadline23 Jun 2020
Contract start7 Jul 2020
Contract end5 Jul 2024
Procedureopen
SME suitableYes
OCIDocds-b5fd17-e3271016-dcc4-4ee3-8e65-d793afb84851

Awards (4)

This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £1,000,000.

SupplierValueDateStatus
Cambridge Spark Limited £24,000 2 Jan 2025 active
HFA Healthcare Limited shared £1,000,000 22 Jan 2021 active
Larova GmbH shared £1,000,000 22 Jan 2021 active
Thermo Fisher Scientific Baltics UAB shared £1,000,000 22 Jan 2021 active

description

In response to the COVID-19 Vaccine manufacture programme, CPI need to secure supply of Nucleotides tohelp develop a self-amplifying RNA Vaccine. For more information please see the tender documents at https://ne1procurementservices.com/

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
9 Feb 2021 Award (award) · 90182477-29ce-4c76-ae98-6a2b35264bf2-411718
28 Jan 2025 Award (award) · 41eedfb1-d87d-45f3-bbb7-ee2271240b14-820023

more from CENTRE FOR PROCESS INNOVATION LIMITED

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.